Sickle cell disease is associated with decreased HIV but higher HBV and HCV comorbidities in U.S. hospital discharge records: a cross-sectional study
- PMID: 22628662
- PMCID: PMC3456988
- DOI: 10.1136/sextrans-2011-050459
Sickle cell disease is associated with decreased HIV but higher HBV and HCV comorbidities in U.S. hospital discharge records: a cross-sectional study
Abstract
Objective: Some studies suggest that HIV infection progresses slowly in patients with sickle cell disease (SCD). The authors aimed to determine the relationships between SCD and HIV infection.
Methods: National Hospital Discharge Survey data from adult African-Americans in the period of 1997-2009 were analysed. The comorbidities of SCD with HIV infections in hospital discharges were analysed. Multiple logistic regression was used to test the association between SCD and HIV. For comparative purposes, the relationships of SCD with hepatitis B virus (HBV) and hepatitis C virus (HCV) were also assessed.
Results: 423,431 records were divided into two time periods 1997-2003 (53% of records) and 2004-2009 (47% of records). The frequency of HIV diagnosis was lower in patients with SCD (1.5% vs 3.3% in patients without SCD). In logistic regression, SCD diagnosis was associated with an OR of 0.24 (95% CI 0.18 to 0.32) for HIV diagnosis in the first period and with an OR of 0.31 (95% CI 0.22 to 0.42) in the second period. In contrast, SCD was associated with higher risk of HCV (OR=2.01, 95% CI 1.56 to 2.59 in the first period and OR=2.12, 95% CI 1.71 to 2.63 in the second period). SCD was also associated with a higher risk of HBV (OR=1.15, 95% CI 0.72 to 1.83 in the first period and OR=1.82, 95% CI 1.24 to 2.68 in the second period).
Conclusions: The lower risk of HIV comorbidity, but not HCV and HBV, with SCD is consistent with the possibility that SCD has a unique effect in altering the risk of HIV infection or progression. Investigation of how the haemolytic and immunological changes of SCD influence HIV might lead to new therapeutic or preventive approaches.
Figures
Comment in
-
Does sickle cell disease protect against HIV/AIDS?Sex Transm Infect. 2012 Nov;88(7):533. doi: 10.1136/sextrans-2012-050613. Epub 2012 Jun 20. Sex Transm Infect. 2012. PMID: 22717473 No abstract available.
References
-
- Centers for Disease Control and Prevention (CDC) HIV surveillanced United States, 1981-2008. MMWR Morb Mortal Wkly Rep. 2011;60:689–93. - PubMed
-
- Brousseau DC, Panepinto JA, Nimmer M, et al. The number of people with sickle-cell disease in the United States: national and state estimates. Am J Hematol. 2010;85:77–8. - PubMed
-
- Castro O, Saxinger C, Barnes S, et al. Prevalence of antibodies to human immunodeficiency virus and to human T cell leukemia virus type I in transfused sickle cell disease patients. J Infect Dis. 1990;162:743–5. - PubMed
-
- Bagasra O, Steiner RM, Ballas SK, et al. Viral burden and disease progression in HIV-1-infected patients with sickle cell anemia. Am J Hematol. 1998;59:199–207. - PubMed
-
- Kourtis AP, Bansil P, Johnson C, et al. Children with sickle cell disease and human immunodeficiency virus-1 infection: use of inpatient care services in the United States. Pediatr Infect Dis J. 2007;26:406–10. - PubMed
Publication types
MeSH terms
Grants and funding
- 1P30HL107253/HL/NHLBI NIH HHS/United States
- SC1GM082325/GM/NIGMS NIH HHS/United States
- HHSN268200617182C/PHS HHS/United States
- RCMI-NIH 2G12RR003048/RR/NCRR NIH HHS/United States
- SC1 GM082325/GM/NIGMS NIH HHS/United States
- G12 RR003048/RR/NCRR NIH HHS/United States
- P30 HL107253/HL/NHLBI NIH HHS/United States
- P50 HL118006/HL/NHLBI NIH HHS/United States
- R25 HL003679/HL/NHLBI NIH HHS/United States
- R01 HL079912/HL/NHLBI NIH HHS/United States
- UH1 HL003679/HL/NHLBI NIH HHS/United States
- UH1 HL03679/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical